Business

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies - Fierce Biotech

F

Published by FierceBiotech By Nick Paul Taylor · 31 August 2026 at 16:18

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies - Fierce Biotech — Image · FierceBiotech

What the report says

Eli Lilly has

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting